In a significant step forward for the development of a potential new cancer treatment, scientists have found how a common cold virus can kill tumours and trigger an immune response, like a vaccine, when injected into the blood stream.
Researchers from Britain's Leeds University and the Institute of Cancer Research (ICR) said by hitching a ride on blood cells, the virus was protected from antibodies in the blood stream that might otherwise neutralise its cancer-fighting abilities.
The findings suggest viral therapies like this, called reovirus, could be injected into the blood stream at routine outpatient appointments - like standard chemotherapy - making them potentially suitable for treating a range of cancers.
The study, part-funded by the charity Cancer Research UK and conducted on 10 patients with advanced bowel cancer, confirmed that reovirus attacks on two fronts - killing cancer cells directly and triggering an immune response that helps eliminate leftover cancer cells.
"Viral treatments like reovirus are showing real promise in patient trials. This study gives us the very good news that it should be possible to deliver these treatments with a simple injection into the blood stream," said Kevin Harrington from ICR, who co-led the study and published it in the journal Science Translational Medicine on Wednesday.
Harrington said if viral treatments had been found only to work when injected directly into tumours, that would have been a significant barrier to their widespread use.
"But the finding that they can hitch a ride on blood cells will potentially make them relevant to a broad range of cancers," he said.
Reovirus is being investigated by several research teams around the world - including scientists at Canada's Oncolytics Biotech Inc - because it has shown an ability to infect and kill cancer cells without affecting normal tissue.
"We also confirmed that reovirus was specifically targeting cancer cells and leaving normal cells alone, which we hope should mean fewer side-effects for patients," Harrington said.
Cancer killed 7.6 million people worldwide in 2008, the most recent year for which the World Health Organisation has full data. The number of cancer cases is expected to surge by more than 75 percent across the world by 2030.
The 10 patients in the study were all due to have surgery on tumours that had spread to their livers. During outpatient appointments in the weeks before their surgery, they were given up to five doses of the experimental reovirus treatment.
When researchers looked at pieces of tissue removed during surgery up to four weeks later, they found what they described as "viral factories" of active virus in the tumour - but not in the normal liver tissue.
This confirmed the reovirus had been delivered specifically to the cancer cells after being injected into the blood stream.
"It seems that reovirus is even cleverer than we had thought," said University of Leeds' researcher Alan Melcher.
"By piggybacking on blood cells, the virus is managing to hide from the body's natural immune response and reach its target intact. This could be hugely significant for the uptake of viral therapies like this in clinical practice."
The White House has said a decision will be announced before the G7 summit in Italy on May 26 and 27.
House Freedom Caucus says will back President Donald Trump's healthcare plans
The London-based Environmental Investigation Agency (EIA) estimated that in 2013, at least 93 percent of logging in Mozambique was illegal -- and that most of the illicit timber ended up sold in China.
Erik Solheim told AFP in an interview on Monday that even if the United States withdraws, China and the European Union will step in and take the lead to implement the global agreement on reducing greenhouse gas emissions.
Polyethylene represents 40 percent of Europe's demand for plastic products, mostly in the form of packaging and shopping bags.
The High Court had demanded ministers come up with a plan to tackle illegal levels of nitrogen dioxide pollution, largely caused by diesel emissions, by 3:00 pm (1400 GMT) on Monday.
PEG-2S promises to tackle superbugs that threaten world health
The change affects grazing conditions for the 146,000 or so semi-domesticated reindeer in Norway who feed on lichen and moss under the snow.
The discovery of the giant shipworm, a species never before studied, marked the first time scientists had live specimens in hand, according to an article published this week in American journal Proceedings of the National Academy of Sciences.
As many as one in 45 children are diagnosed with autism spectrum disorder in the United States, according to a recent study by the US Centers for Disease Control and Prevention.
A full 1.6 billion people remain affected by NTDs -- more than 500 million of them children -- but that number is down from more than two billion in 2010, WHO said.
For the first time ever in modern history, a team of scientists Monday documented as what they're describing as large-scale river reorganization as a result of human-caused climate change.
In the next few hours he will receive a healthy kidney thanks to a pioneering system that has made Spain the world leader in organ transplants for the past 25 years.
Japan's corals, the northernmost in the world, could offer important data to bolster knowledge about marine life, as Australia's Great Barrier Reef faces a threat to its survival.
China is the world's largest consumer and producer of tobacco, and the industry provides the government with colossal sums.
During his time leading IAS, Mark Wainberg organised the 13th International AIDS conference in Durban, South Africa, and he also co-chaired the same conference in Toronto in 2006.